Cargando…

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation

Detalles Bibliográficos
Autores principales:	Hiratsuka, Masahiro, Zhou, Yitian, Lauschke, Volker M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375317/ https://www.ncbi.nlm.nih.gov/pubmed/34422026 http://dx.doi.org/10.3389/fgene.2021.736626

Ejemplares similares

Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
por: Schmidlen, Tara, et al.
Publicado: (2020)

Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence
por: Schuh, Michael J., et al.
Publicado: (2020)

Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health
por: Zhou, Yitian, et al.
Publicado: (2021)

Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project
por: Blagec, Kathrin, et al.
Publicado: (2018)

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
por: Monnin, Pierre, et al.
Publicado: (2019)

HUGO Statement on Pharmacogenomics (PGx): Solidarity, Equity and Governance
Publicado: (2007)

PGxCorpus, a manually annotated corpus for pharmacogenomics
por: Legrand, Joël, et al.
Publicado: (2020)

Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency
por: Matišić, Vid, et al.
Publicado: (2023)

Pharmacogenomic network analysis of the gene-drug interaction landscape underlying drug disposition
por: Zhou, Yitian, et al.
Publicado: (2019)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

An optimized prediction framework to assess the functional impact of pharmacogenetic variants
por: Zhou, Yitian, et al.
Publicado: (2018)

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing
por: Zhou, Yitian, et al.
Publicado: (2022)

Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
por: Blagec, Kathrin, et al.
Publicado: (2022)

Structural variation of the coding and non-coding human pharmacogenome
por: Tremmel, Roman, et al.
Publicado: (2023)

Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation
por: Lauschke, Volker M., et al.
Publicado: (2020)

Drug Use among Nursing Home Residents in Denmark for Drugs Having Pharmacogenomics Based (PGx) Dosing Guidelines: Potential for Preemptive PGx Testing
por: Vermehren, Charlotte, et al.
Publicado: (2020)

Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods
por: Zhai, Song, et al.
Publicado: (2022)

Editorial: Pharmacogenomics of Adverse Drug Reactions
por: Siddiqui, Moneeza K., et al.
Publicado: (2022)

Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
por: Shaman, Jeffrey A., et al.
Publicado: (2022)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Emerging trends in pharmacogenomics: from common variant associations toward comprehensive genomic profiling
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2023)

Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines
por: Westergaard, Niels, et al.
Publicado: (2021)

Editorial: The role of pharmacogenomics in addressing health disparities: the path, the promise, and the barriers
por: Roman, Youssef M.
Publicado: (2023)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Population Pharmacogenomics for Precision Public Health in Colombia
por: Nagar, Shashwat Deepali, et al.
Publicado: (2019)

PGx: Putting Peptides to BED
por: Askenazi, Manor, et al.
Publicado: (2015)

Cross-Comparison of Exome Analysis, Next-Generation Sequencing of Amplicons, and the iPLEX(®) ADME PGx Panel for Pharmacogenomic Profiling
por: Chua, Eng Wee, et al.
Publicado: (2016)

Pharmacogenomics of acetaminophen in pediatric populations: a moving target
por: Krasniak, Anne E., et al.
Publicado: (2014)

The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations
por: Nagaraj, Shivashankar H., et al.
Publicado: (2021)

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data
por: Zhou, Yitian, et al.
Publicado: (2022)

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
por: Mroz, Pawel, et al.
Publicado: (2021)

Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug–Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients
por: Westergaard, Niels, et al.
Publicado: (2020)

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023)

Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
por: Tafazoli, Alireza, et al.
Publicado: (2023)

Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results
por: Zhou, Yitian, et al.
Publicado: (2022)

Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
por: Schuh, Michael J.
Publicado: (2019)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
por: Koomdee, Napatrupron, et al.
Publicado: (2022)

Editorial: Pharmacogenomics in neglected populations
por: Botton, Mariana R., et al.
Publicado: (2022)

Integrating rare genetic variants into pharmacogenetic drug response predictions
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2018)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
por: Patrinos, George P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mm3738am9ls9n8hvq7vvm7ppl6